Pregnant with COVID-19 and Rubella: Impact in the Maternal and Newborn Health

Abstract

Since December 2019, COVID-19 has become major global public health problem. The understanding of SARS-CoV-2, especially the effect on pregnant women and neonates, is still not fully elucidated. This report case describes a pregnant with COVID-19 and rubella. SARS-CoV-2 nucleic acid was not detected in the neonate just after birth, indicating that there was not vertical transmission. Although anti-SARS-CoV-2 Immunoglobulin G (IgG) antibody and anti-Rubella Virus IgG antibody were detected in the newborn serum, anti-SARS-CoV-2 (Immunoglobulin M) IgM and anti-Rubella Virus IgM were not detected. The observations may suggest transplacental transmission of coronavirus and rubella antibodies, ensuring immediate immunity against these pathogens to newborn.